DCG(I) Circular on Re-labeling_Re-Printing of revised prices as per NPPA 2013

To established the safety and efficacy of the FDC of Flupenthixol+Melitracen on 

Cancellation of Permission/license in case an applicant/ manufacturer who fails to launch their product for marketing in the country within a period of six months from obtaining the permission/ license from CDSCO

Export of drugs with Neutral Code-Exemption under Rule 94 of the Drugs & Cosmetics Rules

Directions under Section 33(P) of Drugs and cosmetics Act, 1940 for grant / renewal of manufacturing licences of drug formulations in proper/ generic name only

Directions under Section 33(P) of Drugs and Cosmetics Act, 1940 for Fixed Dose Combinations

An initiative of various stake holders namely Goa Medical Council, Goa Voluntary Health Association of Goa, Chemist & Druggist Association, Indian Pharmaceutical Association, Goa Branch and the Directorate of Food and Drugs Administration; for the last two years has resulted in the release of Guidelines for Prescription Writing and Handling of Prescription and Prescription Medicines, which has

Regulation of Import and manufacture of certain medical devices covered under the categories of notified medical devices-reg

Marketing of formulations of analgin with the complete indications as approved by the Drugs Technical Advisory Board

FSSAI prescribes procedures for forwarding samples to referal labs by FBO